They aren't just growing plants; they are building the ultimate tech foundation for a multi-billion dollar pharma acquisition. The math is simple, the IP is locked. ๐งซ๐ผ
โ #AuroraCannabis#BigPharma#Biotech#StocksToWatch $acb
Is $ACB the ultimate Big Pharma takeover target? ๐ฉบ๐
โForget rec weed. Aurora has built a massive medical IP & patent fortress that looks more like a biotech than a traditional cultivator. What they hold: ๐งต๐
โ#CannabisStocks#PotStocks#Biotech#Pharma
๐จ The Takeover Play ("Dressing up the Bride"): To turn raw materials into a global drug (like Sativex), you need $100M+ for Phase III trials. $ACB can't fund that alone. But a cash-rich Big Pharma giant looking to bypass years of R&D? Perfect match.
While regular cannabis stocks trade at 1x Sales, specialized medical firms command 3x-5x multiples. If Wall Street reprices Aurora's EU-GMP dominance in Europe (Germany, Poland), the valuation gap will close FAST. ๐ $acb
๐ข BREAKING: The US Supreme Court has upheld the constitutional rights of cannabis consumers to legally possess firearms.
For years, NORML has argued that responsible consumers should not be treated as second-class citizens under the law. Today's ruling is a major victory for cannabis freedom and a powerful affirmation that constitutional rights do not disappear because someone uses marijuana.
๐ Read more: https://t.co/U36IFHEcoR
#2A #SCOTUS